AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230321261A1
SERIAL NO

17957302

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antibody-drug conjugates (ADCs) binding to human AXL for therapeutic use, particularly for treatment of melanoma in combination with one or more MAPK pathway inhibitors such as, e.g., a BRAF inhibitor and/or a MEK inhibitor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENMAB A/SBREDGADE 34 COPENHAGEN 1260

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BOSHUIZEN, Julia Amsterdam, NL 6 13
BREIJ, Esther Utrecht, NL 29 98
DE, JONG Rob Utrecht, NL 20 56
KOOPMAN, Louise Utrecht, NL 7 12
PARREN, Paul Odijk, NL 234 3032
PEEPER, Daniel Amstelveen, NL 4 12
SATIJN, David Utrecht, NL 76 377
VAN, DEN BRINK Edward Utrecht, NL 38 279
VAN, DIJKHUIZEN RADERSMA Riemke Utrecht, NL 12 69
VERZIJL, Dennis Amstelveen, NL 24 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation